RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease

Area of Science:

• Molecular Biology
• Gene Regulation
• Biochemistry

Background:

• Accurate gene expression depends on RNA polymerase II (RNAPII) carboxy-terminal domain (CTD) phosphorylation.
• The CTD acts as a regulatory platform, the 'CTD code', crucial for transcription.
• Transcription-associated cyclin-dependent kinases (tCDKs) and phosphatases control RNAPII phosphorylation-dephosphorylation cycles.

Purpose of the Study:

• To synthesize current knowledge on RNAPII phosphorylation dynamics.
• To highlight mechanistic principles governing the CTD code.
• To explore links between CTD phosphorylation and human diseases, including therapeutic strategies.

Main Methods:

• Literature review and synthesis of existing research on RNAPII CTD phosphorylation.
• Analysis of mechanistic principles of kinase-phosphatase regulation.
• Examination of disease associations and potential therapeutic targets.

Main Results:

• RNAPII CTD phosphorylation dynamics are tightly regulated by tCDKs and phosphatases.
• This regulation couples RNA synthesis with co-transcriptional processing and chromatin modification.
• Imbalances in CTD phosphorylation disrupt transcriptional fidelity, RNA maturation, and genome stability.

Conclusions:

• The CTD code is a central regulatory system integrating RNAPII activity.
• Disruptions in RNAPII phosphorylation are linked to developmental disorders, neurodegeneration, and cancer.
• Targeting this phosphorylation-dependent system offers emerging therapeutic strategies.